Stammdaten
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Unternehmen & Branche
| Name | Longevity Health Holdings, Inc. |
|---|---|
| Ticker | XAGE |
| CIK | 0001842939 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 444.607 USD |
| Beta | 0,28 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,912,811 | -6,905,282 | -4.83 | 2,367,027 | -5,866,873 |
| 2025-09-30 | 10-Q | 425,864 | -1,429,755 | -0.83 | 3,298,979 | -3,977,363 |
| 2025-06-30 | 10-Q | 503,612 | -1,886,438 | -1.56 | 3,719,342 | -3,737,534 |
| 2025-03-31 | 10-Q | 510,353 | -1,505,867 | -1.52 | 3,337,234 | -3,805,285 |
| 2024-12-31 | 10-K | 50,318 | -10,368,261 | -14.56 | 1,473,980 | -4,712,662 |
| 2024-09-30 | 10-Q | 20,519 | -2,878,481 | -4.13 | 2,441,854 | -4,064,557 |
| 2024-06-30 | 10-Q | 12,320 | -3,304,538 | -4.78 | 5,033,855 | -1,371,772 |
| 2024-03-31 | 10-Q | 0 | -3,270,959 | -4.28 | 6,180,343 | -1,391,659 |
| 2023-12-31 | 10-K | 0 | -15,445,087 | -1.46 | 63,948,803 | 24,749,010 |
| 2023-09-30 | 10-Q | 0 | -11,464,769 | -0.62 | 82,223,945 | 20,917,580 |
| 2023-06-30 | 10-Q | 0 | -5,308,952 | -5.00 | 160,300,925 | -45,106,372 |
| 2023-03-31 | 10-Q | -1,828,715 | -1.91 | 158,496,202 | -39,743,801 | |
| 2022-12-31 | 10-K | -9,051,334 | -5.47 | 1,748,547 | -37,790,539 | |
| 2022-09-30 | 10-Q | 0 | -6,067,302 | -6.74 | 155,889,384 | -34,769,115 |
| 2022-06-30 | 10-Q | -346,986 | 155,277,740 | -28,821,777 | ||
| 2022-03-31 | 10-Q | -527,530 | 155,212,812 | -5,297,410 | ||
| 2021-12-31 | 10-K | -329,382 | 155,422,296 | -29,577,046 | ||
| 2021-12-31 | 10-Q | -527,530 | 155,422,296 | -29,577,046 | ||
| 2021-09-30 | 10-Q | 42,655 | 155,576,361 | -4,392,369 | ||
| 2021-06-30 | 10-Q | -6,365 | 315,178 | 17,424 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.